Cardiotoxicity during checkpoint inhibitor therapy in patients with advanced skin cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Lübeck, Universität zu Lübeck, Dissertation, 2021
- Schlagwort
-
Patients
Skin--Cancer
Therapeutics
- Ereignis
-
Veröffentlichung
- (wo)
-
Lübeck
- (wer)
-
Zentrale Hochschulbibliothek Lübeck
- (wann)
-
2022
- Urheber
-
Kurzhals, Jonas Kilian
- Beteiligte Personen und Organisationen
-
Langan, Ewan
- URN
-
urn:nbn:de:gbv:841-20220303121
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:39 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kurzhals, Jonas Kilian
- Langan, Ewan
- Zentrale Hochschulbibliothek Lübeck
Entstanden
- 2022
Ähnliche Objekte (12)
Cardiotoxicity risk factors with immune checkpoint inhibitors
Preclinical models of cardiotoxicity from immune checkpoint inhibitor therapy
Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity
Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance
A comprehensive review on immune checkpoint inhibitors induced cardiotoxicity characteristics and associated factors
A multimodality score strategy for assessing the risk of immune checkpoint inhibitors related cardiotoxicity
Overview of the Cardiotoxicity Induced by PD-1/PD-L1 Immune Checkpoint Inhibitor in Critical Care
Immune checkpoint inhibitor-induced cardiotoxicity in patients with lung cancer: a systematic review and meta-analysis
Revisiting the association between skin toxicity and better response in advanced cancer patients treated with immune checkpoint inhibitors
Advanced Imaging Modalities to Monitor for Cardiotoxicity
Hyperprogressive disease rarely occurs during checkpoint inhibitor treatment for advanced melanoma
Cardiotoxicity risk factors with immune checkpoint inhibitors
Preclinical models of cardiotoxicity from immune checkpoint inhibitor therapy
Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity
Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance
A comprehensive review on immune checkpoint inhibitors induced cardiotoxicity characteristics and associated factors
A multimodality score strategy for assessing the risk of immune checkpoint inhibitors related cardiotoxicity
Overview of the Cardiotoxicity Induced by PD-1/PD-L1 Immune Checkpoint Inhibitor in Critical Care
Immune checkpoint inhibitor-induced cardiotoxicity in patients with lung cancer: a systematic review and meta-analysis
Revisiting the association between skin toxicity and better response in advanced cancer patients treated with immune checkpoint inhibitors
Advanced Imaging Modalities to Monitor for Cardiotoxicity
Hyperprogressive disease rarely occurs during checkpoint inhibitor treatment for advanced melanoma
Cardiotoxicity risk factors with immune checkpoint inhibitors
Preclinical models of cardiotoxicity from immune checkpoint inhibitor therapy
Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity
Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance
A comprehensive review on immune checkpoint inhibitors induced cardiotoxicity characteristics and associated factors
A multimodality score strategy for assessing the risk of immune checkpoint inhibitors related cardiotoxicity
Overview of the Cardiotoxicity Induced by PD-1/PD-L1 Immune Checkpoint Inhibitor in Critical Care
Immune checkpoint inhibitor-induced cardiotoxicity in patients with lung cancer: a systematic review and meta-analysis
Revisiting the association between skin toxicity and better response in advanced cancer patients treated with immune checkpoint inhibitors
Advanced Imaging Modalities to Monitor for Cardiotoxicity